• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Study ties eye illness to volcanic fog

Emily

Editor, Senior Moderator
http://www.hawaiimedicaljournal.org/HMJ_Dec11.pdf
HAWAI?I MEDICAL JOURNAL, DECEMBER 2011, VOL 70, NO 12
Ocular Findings in Volcanic Fog Induced Conjunctivitis
Jorge G. Camara MD and John Kenneth D. Lagunzad MD
Abstract
Objective: To describe the ocular signs and symptoms of patients complaining of eye irritation due to volcanic fog (vog).
Methods: The study utilized a non-comparative, retrospective chart review of 30 patients who had a chief complaint of eye irritation, which the subjects attributed to vog. Ocular signs and symptoms are described and related to the ambient concentration of sulfur dioxide (SO2), particulate matter sized 2.5 microns (PM2.5), and vog visibility in O?ahu during the period of the study.
Results: Ocular signs noted were conjunctival injection (100%), clear mucous
discharge (100%), papillary reaction (100%), punctal edema (80%), eyelid swelling (73.3%) and chemosis (63.3%). Ocular symptoms were itchiness (100%), foreign body sensation (100%), tearing (96.6%) and burning sensation (90%). All patients had concurrent respiratory symptoms. During the period of study, the highest 24-hour average concentration of particulate matter sized 2.5 microns (PM2.5) was 49.04 μg/m3 and vog was visually present.
Conclusions: Patients complaining of eye irritation due to vog have observable ocular signs and symptoms.

Full text at link in PDF format.
 
Back
Top Bottom